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Materials and Methods 
 
Plasmid construction 
 
All constructs were generated using standard procedures. The backbones were linearized using 
restriction digestion or PCR, and inserts were generated using PCR or gBlock synthesis (IDT). A 
list of all plasmids reported in this manuscript is included in Table S1, and all plasmids and maps 
are deposited with Addgene. 
 
Tissue culture  
 
The Flp-In™ T-REx™ 293 Cell Line (Human Embryonic Kidney cells that contain a single 
stably integrated FRT site at a transcriptionally active genomic locus, and stably expressing the 
tetracycline repressor protein) was purchased from Thermo Fisher Scientific (R78007). Cells 
were cultured in a humidity controlled chamber at 37°C with 5% CO2 in media containing 
DMEM supplemented with 10% FBS, 1 mM sodium pyruvate, 1 unit/ml penicillin, 1 μg/ml 
streptomycin, 2 mM L-glutamine and 1X MEM non-essential amino acids. 100 ng/mL 
doxycycline was added whenever expression is needed from a CMV-TO promoter. All stably 
integrated transgenes were inducible with doxycycline, which was only added one day before 
characterization. Trimethoprim (TMP) was delivered at 1 µM. Rapamycin was delivered at 5 
nM. Epidermal growth factor (EGF) was delivered at 25 ng/mL. SHIELD1 was delivered at 1 
µM. ASV was delivered at 3 µM. For bulk measurement of pulsing dynamics, cells were 
cultured in the presence of 40 µM biliverdin, and rapamycin was added at different time points 
before preparation for flow cytometry. For stimulation with EGF, cells were cultured to near 
100% confluency before transfection, and, one day after transfection, exposed to 40 µM 
biliverdin, 25 ng/mL EGF, and 100 ng/mL doxycycline for 6 hours prior to flow cytometry 
analysis. 
 
Transient transfection 
 
293 cells were seeded at a density of 0.05 x 106 cells per well of a 24-well plate and cultured 
under standard conditions overnight. The following day, the cells were transfected with plasmid 
constructs using Lipofectamine 2000 (Thermo Fisher) as per manufacturer’s protocol. 
 
Flow cytometry 
 
Two days after transfection, cells were prepared for flow cytometry by trypsinizing with 30µL of 
0.05% trypsin for 1 min at room temperature. Protease activity was neutralized by resuspending 
the cells in buffer containing 70 µL of HBSS with 2.5mg/ml Bovine Serum Albumin (BSA). For 
cells stimulated with EGF, cells were resuspended in buffer containing 70µL of HBSS with 2.5 
mg/mL BSA and 1 mM EDTA. Cells were then filtered through a 40 μm cell strainer and 
analyzed by flow cytometry (MACSQuant VYB, Miltenyi or CytoFLEX, Beckman Coulter). We 
used the EasyFlow Matlab-based software package developed in-house by Yaron Antebi to 
process flow cytometry data. 
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Annexin V staining 
 
Staining was performed using a standard kit (ThermoFisher A13201). One day after transfection, 
cell culture medium was removed from each well, and replaced with 7.5 µL FITC-conjugated 
annexin V within 150 µL binding buffer. After incubation in dark at 37C for 15 min, the 
staining medium was removed, and the cells trypsinized for flow cytometry analysis. 
 
Fluorescent signal quantification from flow cytometric measurements 
 
To maximize the observable reporter dynamic range, we selected and compared cells with the 
highest expression of the co-transfection marker, which showed the largest separation of basal 
reporter fluorescence from cellular autofluorescence. For each sample in a comparison group 
(experiments performed in the same batch and data shown on the same plot), we calculated the 
98 and 99.5 percentiles of fluorescence of the co-transfection marker (mCherry in most cases). 
We identified the sample with the lowest 98 percentile value, and used its 98 and 99.5 percentiles 
as lower and upper limits to gate on all samples. For all cells within the gate in each sample, we 
fit the distribution of the logarithm of their signal fluorescence (Citrine in most cases) with skew 
Gaussian distributions, i.e.  N*normcdf(x,m,k)*normpdf(x,m,s) in Matlab using non-linear least-
square fitting, and reported the mode (peak position, representing the reporter level that’s most 
likely to be observed) of the resulting fit (Fig. S1A). Here, the normcdf(x,µ,σ) and 
normpdf(x,µ,σ) functions are cumulative probability density and probability density functions for 
a Gaussian distribution respectively, and the parameter n is a normalization factor, m=µ is the 
mean of the Gaussian function, s=σ is the inverse standard deviation of the Gaussian, and k 
parameterizes skewness. No gating was performed on monoclonal cells with the genomically 
integrated pulsing circuit, because, unlike transient transfection, here expression variation is 
already limited. 
 
Calculating reduction index from flow cytometric measurements 
 
To calculate the reduction of cell numbers, we compared the effects of various treatments on cell 
numbers, comparing each measurement to a negative control transfected with only a fluorescent 
marker, and using the size of the untransfected cell population for internal normalization. To do 
this, we proceeded in several steps: First, we fit the distribution of the logarithm of 
autofluorescence collected in the Citrine channel from mock transfected cells with the MATLAB 
function N0*normcdf(x,m0,k0) *normpdf(x,m0,s0) using non-linear least-square fitting. Here, the 
parameters n0, m0, s0, and k0 and functions normcdf() and normpdf() have the same meanings as 
in the previous section. Reference values for m0, s0, k0, were thus determined from measurement 
of autofluorescence in untransfected cells and fixed for subsequent two-component  model fits. 
Second, for each transfected well, we fit the distribution of the logarithm of Citrine signal with 
N1*normcdf(x,m0,k0)* normpdf (x,m0,s0) +N2*normpdf(x,m2,s2), where N1, N2, m2, s2 were free 
parameters and m0, s0, k0 were fixed to values extracted from autofluorescence fit. The area 
under the curve N1* normcdf(x,m0,k0)*normpdf(x,m0,s0) (“area a0” and “area a” in Fig. S5B) 
corresponds to the number of untransfected cells, which serves as an internal reference. Third, 
we subtracted the number of untransfected cells from the total number of cells to get the number 
of transfected cells that survived (“area b0” and ”area b” in Fig. S5B). For each sample, the 
number of transfected cells that survived was then normalized to the number of untransfected 
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cells, and the ratio between normalized survival number in that condition ((area a)/(area b) in 
Fig. S5B) and normalized survival number in the Citrine-only control condition ((area a0)/(area 
b0) in Fig. S5B) was defined as survival percentage. Finally, the reduction index was defined as 
1-survival percentage.  
 
In experiments with SOSCA cells, a small fraction of  these cells silenced their transgene 
expression during cell culture. To make sure that we were only analyzing cells that do express a 
Ras activator, we gated on mCherry that’s co-expressed with SOSCA, and excluded the mCherry– 
population. This co-expressed mCherry marker was also utilized in co-culture experiments, to 
distinguish SOSCA/EGFRvIII cells from control cells, so that we could calculate their reduction 
index separately. 
 
Mathematical modeling of the bandpass circuit 
 
To analyze the behavior of the bandpass circuit, we constructed a minimal ordinary differential 
equation model representing the key components and interactions within the circuit. The model 
incorporated three types of interactions: protein production, first-order degradation, and cleavage 
by proteases. In the model, protease regulation of substrates is described by differential equations 
of the following form: 
  
 
𝑑[𝑆𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒]
𝑑𝑡
=  𝐴 − 𝑘𝑐𝑎𝑡
𝑃𝑟𝑜𝑡𝑒𝑎𝑠𝑒[𝑃𝑟𝑜𝑡𝑒𝑎𝑠𝑒][𝑆𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒] − 𝑘𝑑𝐴[𝑆𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒] (1) 
 
𝑑[𝑆𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒𝑐𝑙𝑒𝑎𝑣𝑒𝑑]
𝑑𝑡
=  𝑘𝑐𝑎𝑡
𝑃𝑟𝑜𝑡𝑒𝑎𝑠𝑒[𝑃𝑟𝑜𝑡𝑒𝑎𝑠𝑒][𝑆𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒] − 𝑘𝑑𝐵[𝑆𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒𝑐𝑙𝑒𝑎𝑣𝑒𝑑] (2) 
 
 
Here, 𝐴 represents the production rate of a proteolytic substrate, 𝑘𝑐𝑎𝑡
𝑃𝑟𝑜𝑡𝑒𝑎𝑠𝑒 represents the 
catalytic coefficient, assuming that proteolysis can be described as a Michaelis-Menten reaction 
far from saturation, and the first-order degradation rates 𝑘𝑑𝐴 and 𝑘𝑑𝐵 represent degradation 
through basal cellular degradation pathways. These rate constants can take higher or lower 
values depending on whether the substrate protein and its cleaved form are unstable or stable, 
respectively.  
 
To simplify the analysis without loss of generality, we set 𝐴 = 1 in the equations for fluorescent 
reporters, effectively using arbitrary normalized units for the fluorescent protein concentrations.  
[Substrate] in the normalized version thus corresponds to [Substrate]/A in the original version. 
 
We first considered a CitDHFR reporter, whose DHFR degron can be removed by TEVP with a 
coefficient 𝑘𝑐𝑎𝑡
𝑇𝐸 . In its initial form, the reporter degrades at rate 𝑘𝑑1 (Equation 3), while  its 
cleaved product, Cit, degrades at a rate 𝑘𝑑2 (Equation 4). 
 
𝑑𝐶𝑖𝑡𝐷𝐻𝐹𝑅
𝑑𝑡
= 1 − 𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅] − 𝑘𝑑1[𝐶𝑖𝑡𝐷𝐻𝐹𝑅] (3) 
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𝑑𝐶𝑖𝑡
𝑑𝑡
=  𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅] − 𝑘𝑑2[𝐶𝑖𝑡] (4) 
 
The steady-state solutions for Eqs. 3, 4 are: 
 
𝐶𝑖𝑡𝐷𝐻𝐹𝑅 =
1
𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃] + 𝑘𝑑1
(5) 
 
𝐶𝑖𝑡 =
𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃]
𝑘𝑑2(𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃] + 𝑘𝑑1)
(6) 
 
Experimentally measured reporter fluorescence corresponds to the sum 𝐶𝑖𝑡𝐷𝐻𝐹𝑅 + 𝐶𝑖𝑡. The 
absolute value of the independent variable [TEVP] is not known. However, based on 
experiments in which protein expression levels correlated linearly with the amount of transfected 
plasmid (Fig. S4A), we substituted the concentration of transfected plasmid, 𝑝𝑇𝐸, for [𝑇𝐸𝑉𝑃] in 
all equations, effectively absorbing the constant of proportionality relating [TEVP] and 𝑝𝑇𝐸 into 
the 𝑘𝑐𝑎𝑡
𝑇𝐸  values. With these simplifications, measured fluorescence can be written: 
 
𝐶𝑖𝑡𝑡𝑜𝑡𝑎𝑙 = 𝐶𝑖𝑡𝐷𝐻𝐹𝑅 + 𝐶𝑖𝑡 =
𝑘𝑐𝑎𝑡
𝑇𝐸 𝑝𝑇𝐸
𝑘𝑑2
+ 1 
𝑘𝑐𝑎𝑡
𝑇𝐸 𝑝𝑇𝐸 + 𝑘𝑑1
(7)
 
 
Using Matlab’s curve fitting toolbox, we determined best fit values of the parameters 𝑘𝑐𝑎𝑡
𝑇𝐸 , 𝑘𝑑1 
and 𝑘𝑑2 by fitting Eq. 7 to the experimentally measured 𝑝𝑇𝐸- 𝐶𝑖𝑡𝑡𝑜𝑡𝑎𝑙 curve (Fig. 3B). 
 
To model the repression arm of the bandpass circuit, we must take into account the mutual 
inhibitory activities of TVMVP and HCVP in the circuit. These protease-protease equations take 
on the general form outlined in Eqs 1, 2. However, because reporter and protease concentrations 
are measured in different units (fluorescence and plasmid concentration, respectively), their 
production rates cannot both be arbitrarily set to 1. Instead, we denoted the protease production 
rate 𝐵, to account for the different units used for these two species. Specifically, for 1 unit of 
plasmid input to produce 1 unit of protease at steady-state, B must equal the degradation rate of 
the protease multiplied by the amount of plasmid input (𝑝𝑃𝑟𝑜𝑡𝑒𝑎𝑠𝑒), as shown below in Equations 
8 and 9. 
  
𝑑[𝑇𝑉𝑀𝑉𝑃]
𝑑𝑡
= 𝑘𝑑𝑇𝑉𝑝𝑇𝑉 − 𝑘𝑐𝑎𝑡
𝐻𝐶 [𝐻𝐶𝑉𝑃][𝑇𝑉𝑀𝑉𝑃] −  𝑘𝑑𝑇𝑉[𝑇𝑉𝑀𝑉𝑃] (8) 
  
𝑑[𝐻𝐶𝑉𝑃]
𝑑𝑡
=  𝑘𝑑𝐻𝐶𝑝𝐻𝐶 −  𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃][𝐻𝐶𝑉𝑃] − 𝑘𝑑𝐻𝐶[𝐻𝐶𝑉𝑃] (9) 
 
At steady-state, the concentration of TVMV protease can be expressed as a function of the 
plasmid inputs of TVMVP and HCVP: 
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[𝑇𝑉𝑀𝑉𝑃] =
𝑊 + (𝑊2 + 4𝑘𝑐𝑎𝑡
𝑇𝑉 𝑘𝑑𝑇𝑉
2 𝑘𝑑𝐻𝐶𝑝𝑇𝑉)
1
2
2𝑘𝑐𝑎𝑡
𝑇𝑉 𝑘𝑑𝑇𝑉
(10) 
 
where 𝑊 ≡ 𝑘𝑑𝑇𝑉𝑘𝑐𝑎𝑡
𝑇𝑉 𝑝𝑇𝑉 − 𝑘𝑑𝐻𝐶𝑘𝑑𝑇𝑉 − 𝑘𝑐𝑎𝑡
𝐻𝐶𝑘𝑑𝐻𝐶𝑝𝐻𝐶. The reporter repressed by TVMVP is 
denoted 𝐶𝑖𝑡 when not cleaved (first-order degradation rate 𝑘𝑑3), and 𝐶𝑖𝑡𝑁𝑑𝑒𝑔 when cleaved by 
TVMVP to expose an N-end degron (first-order degradation rate 𝑘𝑑4).We then used a procedure 
similar to Eqs. 3-7 to express reporter expressions in terms of [TVMVP]: 
𝐶𝑖𝑡 =
1
𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃] + 𝑘𝑑3
(11∗) 
 
𝐶𝑖𝑡𝑁𝑑𝑒𝑔 =
𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃]
𝑘𝑑4(𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃] + 𝑘𝑑3)
(12∗) 
 
𝐶𝑖𝑡𝑡𝑜𝑡𝑎𝑙 =
𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃]
𝑘𝑑4
+ 1
𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃] + 𝑘𝑑3
(13∗)
 
 
* For all equations denoted with “*”, [TVMVP] takes the value defined in Eq. 10. 
 
We estimated the values of parameters, 𝑘𝑐𝑎𝑡
𝐻𝐶 , 𝑘𝑐𝑎𝑡
𝑇𝑉 , 𝑘𝑑𝐻𝐶 , 𝑘𝑑𝑇𝑉, 𝑘𝑑3, 𝑘𝑑4, by fitting Eq. 13 to 
experimentally measured 𝐶𝑖𝑡𝑡𝑜𝑡𝑎𝑙, 𝑝𝑇𝑉, and 𝑝𝐻𝐶 (Fig. 3C). 
 
To characterize the cooperativity caused by TVMVP-HCVP mutual inhibition, we fit the 
repression curves in Fig. 3C with a sigmoidal function: 
 
𝐶𝑖𝑡𝑡𝑜𝑡𝑎𝑙 =
𝐶
1 + (
𝑝𝑇𝑉
𝐾 )
𝑛 (14) 
The 95% confidence intervals for the Hill coefficient, n, were 0.95 ± 0.13, 2.0 ± 0.4, 𝑎𝑛𝑑 2.4 ±
0.5, for 𝑝𝐻𝐶 values of 0, 50, and 200 ng, respectively. 
 
Finally, for the reporter that’s simultaneously regulated by the activation and repression arms, 
depending on whether the DHFR degron is removed and whether the N-end degron is exposed, 
there are four possible species 𝐶𝑖𝑡𝐷𝐻𝐹𝑅, 𝐶𝑖𝑡𝐷𝐻𝐹𝑅+𝑁𝑑𝑒𝑔, 𝐶𝑖𝑡, and 𝐶𝑖𝑡𝑁𝑑𝑒𝑔, the first-order 
degradation rates of which we denote as 𝑘𝑑𝐴, 𝑘𝑑𝐵, 𝑘𝑑𝐶 , and 𝑘𝑑𝐷, respectively. Similarly, the 
dynamics of these four species can be expressed as: 
 
𝑑𝐶𝑖𝑡𝐷𝐻𝐹𝑅
𝑑𝑡
= 1 –  𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅] −  𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅] −  𝑘𝑑𝐴[𝐶𝑖𝑡𝐷𝐻𝐹𝑅] (15
∗) 
𝑑𝐶𝑖𝑡𝐷𝐻𝐹𝑅+𝑁𝑑𝑒𝑔
𝑑𝑡
=  𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅] −  𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅+𝑁𝑑𝑒𝑔] −
 𝑘𝑑𝐵[𝐶𝑖𝑡𝐷𝐻𝐹𝑅+𝑁𝑑𝑒𝑔] (16
∗)
 
𝑑𝐶𝑖𝑡
𝑑𝑡
=  𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅] − 𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃][𝐶𝑖𝑡] − 𝑘𝑑𝐶[𝐶𝑖𝑡] (17
∗) 
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𝑑𝐶𝑖𝑡𝑁𝑑𝑒𝑔
𝑑𝑡
=  𝑘𝑐𝑎𝑡
𝑇𝐸 [𝑇𝐸𝑉𝑃][𝐶𝑖𝑡𝐷𝐻𝐹𝑅+𝑁𝑑𝑒𝑔] + 𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃][𝐶𝑖𝑡] −  𝑘𝑑𝐷[𝐶𝑖𝑡𝑁𝑑𝑒𝑔] (18
∗) 
  
 
We summed the steady-state solutions of all species from these equations to derive the final 
input-output equation for the bandpass circuit: 
 
 
𝐶𝑖𝑡𝑡𝑜𝑡𝑎𝑙 =
1 + 𝑋 + 𝑌 +
𝑘𝑐𝑎𝑡
𝑇𝐸 𝑝𝑇𝐸𝑋 + 𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃]𝑌
𝑘𝑑𝐷
𝑘𝑐𝑎𝑡
𝑇𝐸 𝑝𝑇𝐸 + 𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃] + 𝑘𝑑𝐴
, (19∗)
 
 
Where 𝑋 ≡
𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃]
𝑘𝑐𝑎𝑡
𝑇𝐸 𝑝𝑇𝐸+𝑘𝑑𝐵
  and 𝑌 ≡
𝑘𝑐𝑎𝑡
𝑇𝐸 𝑝𝑇𝐸
𝑘𝑐𝑎𝑡
𝑇𝑉 [𝑇𝑉𝑀𝑉𝑃]+𝑘𝑑𝐶
 
 
We used this equation to fit the experimentally observed bandpass behavior (Figure 3D).  
 
Cell line construction 
 
Some of the experiments do require more stable/homogenous transgene expression, for which we 
used antibiotic selection to generate cell lines with stably integrated transgenes. Two days after 
transfection in 24-well plates, cells were transferred to 6-well plate and selected with either 50 
µg/mL Hygromycin (Hyg) or 400 µg/mL Geneticin (Gen). SOSCA cells: CMV-TO-MSos-2A-
H2BChe-FlpIn co-transfected with pOG44, Hyg; pulse cells: PB-CMV-TO-rapTEV-teHCV-
hcTVMV-tvDiTEV-Neo co-transfected with a plasmid expressing PiggyBac transposase, Gen; 
EGFRvIII+ cells: PB-CMV-TO-EGFRvIII-IRES-nlsChe co-transfected with a plasmid 
expressing PiggyBac transposase, Gen. After PiggyBac-based integration, monoclonal cell 
populations were established through limiting dilution, and preliminary screening was performed 
to identify clones with highest transgene expression (based on GFP that serves as the scaffold in 
iTEV, and mCherry that’s co-expressed with EGFRvIII), which were used in subsequent 
experiments. Among the pulse cell clones with highest GFP expression, the one with the least 
variance was selected. We then subjected this clone to another round of transgenesis (Hyg, 
CMV-TO-Cer-HO1-FlpIn co-transfected with pOG44) to provide Cerulean as a segmentation 
marker and heme oxygenase-1 to increase the intracellular concentration of biliverdin that’s 
necessary for enhancing iTEV signal. The final cell line was used in time-lapse imaging.  
 
Time-lapse imaging 
 
For time-lapse imaging of pulse dynamics (Figure 3) monoclonal pulse-generation cells were 
mixed with parental wild-type HEK293 cells at a 1:10 ratio. Cells were plated on 24-well glass-
bottom plates which had been coated with 5 µg/mL with hamster fibronectin for 1 hour at room 
temperature. Cells were induced with 100 ng/mL doxycyline overnight in normal culturing 
conditions. The following morning, the media was replaced with imaging media containing 
FluoroBrite DMEM (Thermo Fisher) supplemented with 10% FBS, 1 mM sodium pyruvate, 1 
unit/ml penicillin, 1 μg/ml streptomycin, 2 mM L-glutamine and 1X MEM non-essential amino 
acids and 100 ng/mL doxycycline.  
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All time-lapse images were acquired on an inverted Olympus IX81 fluorescence microscope 
with Zero Drift Control (ZDC), an ASI 2000XY automated stage, iKon-M CCD camera (Andor, 
Belfast, NIR), and a 60x oil objective (1.42 NA). Fluorophores were excited with an X-Cite 
XLED1 light source (Lumen Dynamics). Cells were kept in a custom-made environmental 
chamber enclosing the microscope, with humidified 5% CO2 flow at 37°C. Microscope and 
image acquisition were controlled by Metamorph software (Molecular Devices).  
 
Imaging started approximately 2 hours after changing the media to fluorescent imaging media. 5 
nM rapamycin was added after approximately 2 hours of imaging to induce the pulse. Images 
were acquired every 20 or 25 min, typically for 20-40 hrs. Cells that were in the field of view 
before rapamycin induction and remained alive and visible in the field of view without death for 
at least 20 hours were used for initial data analysis.  
 
For analysis, we only included cells that remained alive throughout the duration of the 
experiment, remained within the field of view, and had detectable signal/background ratio. IFP 
fluorescence intensity is dependent on the biliverdin chromophore. Addition of exogenous 
biliverdin increases IFP fluorescence but also produces IFP-independent background 
fluorescence. For the movies, to minimize background, we omitted biliverdin from the media, 
relying instead on lower concentrations produced endogenously. Under these conditions, IFP 
excitation illumination levels caused some phototoxicity, resulting in a subpopulation of ~50% 
of cells that died within ~7 hours. The remaining cells continued active division until the end of 
the movie, or until exit from the field of view. These cells exhibited a range of IFP fluorescence 
levels overlapping background. 30-60% of these cells in which IFP fluorescence exceeded 
background. About half of this set had morphologies that were amenable to image-based 
segmentation and therefore were analyzed further. Within this group, we verified that the circuit 
dynamics were independent of expression level, as measured by peak IFP fluorescence, 
suggesting that circuit dynamics are not influenced by expression level within this range.  
 
Movie analysis 
 
Matlab-based single-cell tracking and image normalization software was developed in-house by 
Yaron Antebi. 
 
Single-cell tracking and image normalization:  
 
Single-cell tracking and image normalization procedures were performed as previously described 
(70) with a few modifications. Briefly, cells constitutively express cytoplasmic Cerulean as a 
segmentation marker. Due to the diffuse and weak Cerulean signal, manual segmentation was 
frequently required and cell boundaries were identified in part by phase contrast and GFP 
fluorescence images (GFP is the protein identified as the “split scaffold” in Figure 3E. It serves a 
structural role in the context of the IFP reporter, but also fluoresces).  
 
We performed image correction to account and correct for non-uniform illumination as well as 
background. We assumed a time-independent spatially inhomogeneous illumination profile that 
is characteristic of the optical path, 𝐼(𝑥, 𝑦). This was extracted by fitting the low intensity “non-
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cell” pixels in the images with a two dimensional paraboloid. In addition we considered two 
sources of background fluorescence: First, the detector produces a basal pixel value even in the 
absence of light. This value, denoted 𝐵, is spatially homogeneous and time-independent. Second, 
we considered the autofluorescence of the media. This background source changes over time, 
and exhibits a spatial profile proportional to the illumination profile, 𝐴(𝑡) ∗ 𝐼(𝑥, 𝑦). With these 
assumptions, we extracted the corrected fluorescence value using the following equation: 
 
𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑(𝑥, 𝑦, 𝑡) =
𝐹𝑟𝑎𝑤(𝑥, 𝑦, 𝑡) − 𝐵
𝐼(𝑥, 𝑦)
− 𝐴(𝑡) 
 
For generating the supplementary movie, mean intensities < 5% were set to zero and mean 
intensities > 99.5% were set to maximum pixel values to limit the effect of extreme pixel values 
due to noise on image brightness and contrast settings. 
 
Quantification of amplitude and pulse decay:  
Data processing: The amplitude and pulse decay calculations were based on total levels of 
fluorescence in the IFP fluorescent channel. To systematically quantify the fluorescent signal in 
the IFP channel, total IFP signal intensity 𝐼𝐹𝑃(𝑥, 𝑦, 𝑡) was normalized by the total constitutive 
Cerulean signal 𝐶𝐹𝑃(𝑥, 𝑦, 𝑡) and rescaled with a baseline variable (90th percentile of 
𝐼𝐹𝑃(𝑥,𝑦,𝑡)
𝐶𝐹𝑃(𝑥,𝑦,𝑡)
 at 
all 𝑥 positions.) To capture the pulse of IFP signal and avoid distortion of the peak shape, the 
resulting data was smoothed with a Savitzky-Golay filter using a 3rd order polynomial and a 
window length of 9. After smoothing, the data were interpolated to equidistant timepoints of 20 
minute intervals (Fig. 3H).  
 
Fitting: We fit the pulsing dynamics by taking the smoothed and interpolated data and 
subtracting the minimum value of the normalized signal intensity from each timepoint. Using 
MATLAB’s tfest function, the normalized data were deconvolved with a finite impulse signal 
and a third-order linear transfer function resulting in the equation:  
 
𝑦 = 𝑎1𝑒
𝑝1𝑥(𝑡) + 𝑎2𝑒
𝑝2𝑥(𝑡) + 𝑎3𝑒
𝑝3𝑥(𝑡) 
 
The resulting fit was used to determine: (1) the location at which the maximal value of IFP 
occurred and (2) the delay time, τ, after peak signal at which the signal intensity decayed to 50% 
its maximum value. After determining the peak location and τ, the mean and standard deviation 
were calculated. 
 
Data and code availability 
 
The datasets generated and analyzed and the computer code used during the current study are 
available from the corresponding author.  
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Supplementary Text 
 
Characterization and optimization of HCVP and its reporter. 
 
For HCV protease (HCVP), we adopted a previously described construct in which the protease 
and its co-peptide are fused to create a more active single chain protease (38). This HCVP 
initially showed more modest regulation than the other proteases, especially for the repressible 
reporter (Fig. S1D). We reasoned that increasing the protease affinity to its target could improve 
its regulatory range. Indeed, incorporating a pair of hetero-dimerizing leucine zippers (39) in the 
protease and its target improved regulation (Fig. S1D, right). 
 
Characterization and optimization of circuits that selectively reduce Ras-activating cells 
 
To exclude the possibility that SOSCA cells are generally more sensitive to Casp3 activation, we 
first analyzed constitutively dimerized split TEVP variants, one using leucine zippers, and the 
other adopting a RasG12V mutant that binds constitutively to RBD (73) (Fig. S5E). When co-
transfected with the TEVP-activatable Casp3, these control constructs displayed no selectivity 
for SOSCA cells (Fig. S5E), indicating that the regulated Ras-RBD interaction is necessary for the 
selectivity observed in the main text (Fig. 4C). 
 
To assess the contribution of each additional regulatory interaction in the full circuit, we 
systematically removed them one at a time, and compared their effects on control and SOSCA 
cells to the full circuit. Removal of Casp3 inhibition by TVMVP re-introduced substantial 
reduction in control cells (Fig. S6A, left), and removal of TVMVP inhibition by RasTEVP 
increased survival in SOSCA cells (Fig. S6A, middle). By contrast, removal of RasTEVP 
inhibition by TVMVP had no effect on survival in either control or SOSCA cells (Fig. S6A, 
right). These results indicate that Arms 3,4 (Figs. S5A, S6A) are major contributors to full circuit 
performance.  
 
For single-transcript delivery of the full circuit, we interposed a wild type internal ribosome 
entry site (IRES) between Casp3 and RasTEVP coding sequences, followed by one of several 
IRES variant sequences (61) and then the TVMVP (Fig. S6B). Inspired by TVMVP titration 
results (Fig. S5G), we chose variants with ~30% and ~70% of wild-type strength for the second 
IRES (55), and found that the circuit functioned optimally with the ~70% IRES (Fig. S6B). 
 
Response of RasTEVP to EGF stimulation 
 
To assess the response of RasTEVP to a physiological ligand that normally activates the Ras 
pathway, we stimulated cells expressing either RasTEVP or constitutively dimerized and 
membrane-localized TEVP (negative control TEVP) with epidermal growth factor (EGF). When 
co-transfected with a membrane-localized iTEV reporter, the control construct TEVP-mts 
exhibited minimal response to EGF stimulation, whereas RasTEVP displayed a modest  response 
to EGF (Fig. S5C).  
 
Comparison of protease-protease and transcriptional regulatory dynamics 
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In this supplementary section, we use a minimal model to address the question of how a simple 
transcription factor regulatory step differs in dynamics from a simple protease regulatory step. 
To make a controlled comparison between the two kinds of regulation, we assume that shared 
biochemical parameters, such as protein degradation rates, are similar in the two systems. The 
main conclusion is that protease regulation can occur more rapidly than transcriptional regulation 
but with timescales that depend on the direction of regulation. By contrast, transcriptional 
regulation is expected to be slower but show similar timescales in both directions of regulation. 
While we have considered typical biochemical parameter values here, we note that additional 
features of any specific system, including feedback structure, could impact their dynamic 
behavior. Additionally, the quantitative values of the resulting timescales in general depend on 
the specific choice of biochemical parameter values.  
 
Protease-protease regulation. We modeled repression of one protease by another through direct 
cleavage, based on the scheme in Fig 1E. We assume the concentration of the input protease, 
denoted 𝑃0, is maintained at a constant level, with its activity controlled by a small molecule 
input, as in the scheme of Fig 3E. The output protease, denoted 𝑃, is produced at a constant rate 
𝐴, and undergoes first-order degradation with rate 𝛾𝑝. The input protease cleaves the output 
protease at a single cleavage site, converting it to a cleaved form, whose concentration is denoted 
𝑃𝑐, with a cleavage rate constant 𝑘. The cleaved protease irreversibly dissociates at rate 𝑘𝑑, and 
undergoes first-order degradation with rate 𝛾𝑝 for a total rate of elimination of 𝛾𝑝+ 𝑘𝑑. We 
assume a single cleavage for simplicity, but the same conclusions hold true for two independent 
cleavage sites, cleavage of either of which is sufficient to inactivate the output protease.  
 
The reactions in the protease-protease model are as follows, where 𝜙 denotes ‘nothing’: 
 
1. Synthesis of the output protease: 𝜙
𝐴
→𝑃 
2. Degradation of the output protease: 𝑃
𝛾𝑝
→𝜙 
3. Catalytic cleavage of the output protease: 𝑃0 + 𝑃
𝑘
→ 𝑃0 + 𝑃𝑐 
4. Dissociation of the cleaved protease: 𝑃𝑐
𝑘𝑑
→ 𝜙 
5. Degradation of the cleaved protease: 𝑃𝑐
𝛾𝑝
→𝜙 
 
Assuming protease cleavage functions in a linear regime far from saturation, consistent with 
published Km values (23) and our bandpass modeling, the reaction can be expressed as a set of 
ordinary differential equations (ODEs):  
 
𝑑𝑃
𝑑𝑡
= 𝐴 − 𝑘𝑃0𝑃 − 𝛾𝑝𝑃 
𝑑𝑃𝑐
𝑑𝑡
= 𝑘𝑃0𝑃 − 𝑃𝑐(𝑘𝑑 + 𝛾𝑝)  
Because the absolute value of the production rate 𝐴 does not affect the dynamics of the system, 
we arbitrarily set its value to 1 𝑀ℎ−1. For the dissociation rate, we assumed 𝑘𝑑 = 5ℎ
−1 based on 
indirect measurements (71). For the protein degradation rate, we assumed a biologically realistic 
value of 𝛾𝑝 =  0.1ℎ
−1. 
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Based on our bandpass fits (Figs. 3B-D, Methods), cleavage by a protease, when the input 
protease activity is high, occurs at a rate comparable to the rate of degron-mediated degradation 
(∼5ℎ−1). We also assumed that the OFF input protease is 20-fold less active than the ON state 
based on the dynamic range observed in Figure 1. (Note that the value of this regulatory range 
does not affect our conclusions about the timescales of regulation.) Finally, we assumed the 
small-molecule-induced ON-OFF switch reaches steady-state much faster than the other 
reactions, so that the cleavage term can be approximated by a step function, taking one of two 
possible values: 
 
𝑘𝑃0 = 0.25 ℎ
−1 (𝑖𝑛𝑝𝑢𝑡 𝑂𝐹𝐹) or 5 ℎ−1 (𝑖𝑛𝑝𝑢𝑡 𝑂𝑁) 
 
To simulate output dynamics in response to changes in the input, we first set the input protease to 
ON, and the output protease to its steady state value of 𝑃 + 𝑃𝑐. At t=10h, we switched the input 
to OFF and simulated the equations for 70h (10-80h). Finally, we switched the input back to ON 
and simulated another 70h (80h-150h). In Fig. S7, we plot the resulting dynamics of the output 
protease, normalized to its maximum value. Note the asymmetric response time, which is faster 
for input OFFON switch than ONOFF (𝑡1
2
  = 0.32 ℎ−1 vs. 2.3 ℎ−1).  
 
Transcriptional regulation. As a comparison to protease regulation, we modeled a logically 
equivalent transcriptional repression step. The input transcription factor was maintained at a 
constant concentration of 𝑇0, with its activity assumed to be controlled by a small molecule, as 
with the protease. The input transcription factor regulates the output mRNA, 𝑇𝑚, whose 
production follows a standard rate law:  
𝐾
𝐾+𝑇0
𝐴𝑚. 𝑇𝑚 undergoes first-order degradation with rate 
𝛾𝑚. The output protein 𝑇𝑝 is translated from the mRNA at rate 𝐴𝑝, and degraded with rate 𝛾𝑝. 
The reactions are as follows: 
 
1. mRNA synthesis:  𝜙
𝐾
𝐾+𝑇0
𝐴𝑚
→     𝑇𝑚 
2. mRNA degradation: 𝑇𝑚
𝛾𝑚
→ 𝜙 
3. protein synthesis: 𝑇𝑚
𝐴𝑝
→ 𝑇𝑚 + 𝑇𝑝 
4. protein degradation: 𝑇𝑝
𝛾𝑝
→𝜙 
 
These reactions can be converted to ODEs for each of the components: 
 
𝑑𝑇𝑚
𝑑𝑡
=
𝐾
𝐾 + 𝑇0
𝐴𝑚 − 𝛾𝑚𝑇𝑚 
𝑑𝑇𝑝
𝑑𝑡
= 𝐴𝑝𝑇𝑚 − 𝛾𝑝𝑇𝑝 
 
Without loss of generality we set the production rate 𝐴𝑚 = 1 𝑀ℎ
−1 and 𝐴𝑝 = 1 ℎ
−1. We used 
the same protein degradation rate as in the protease regulation case above: 𝛾𝑝 = 0.1ℎ
−1. For 
mRNA degradation, we simulate two values at opposite extremes of the biological range for 
mammalian mRNA (72):𝛾𝑚 = 0.1ℎ
−1 (more stable), and 5ℎ−1 (less stable). As above, we also 
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assumed that the small-molecule-controlled input ON-OFF switch is much faster than the other 
reactions. To match the protease conditions, we assumed 𝑇0 also undergoes a 20-fold regulation, 
from 𝑇0 = 0.5𝐾 (𝑖𝑛𝑝𝑢𝑡 𝑂𝐹𝐹) to 10𝐾 (𝑖𝑛𝑝𝑢𝑡 𝑂𝑁), although we note that the exact dynamic 
range of 𝑇0 or the exact choice of the Hill function does not affect output dynamics. 
 
We simulated this simple model of transcriptional regulation with fast and slow mRNA 
degradation rates, following the same ON  OFF  ON input temporal profile used in the 
protease regulation case. To focus on the timescale of  regulation, we normalized each curve to 
its maximal value. For transcriptional regulation, 𝑡1
2
 = 7.2 ℎ−1 and 17 ℎ−1 for fast and slow 
mRNA decay, respectively, regardless whether the input undergoes ONOFF or OFFON 
switch. When input switches from ON to OFF, protease and transcriptional regulation occurs on 
comparable timescales, although their difference is more apparent in the slower mRNA 
degradation case. When input switches from OFF to ON, however, protease regulation generates 
a much faster response time compared to transcriptional regulation and the ON to OFF switch in 
the protease regulation case (Fig. S7). Intuitively, the dynamics of each process is limited by the 
slowest rate at which a species decays, which is the relatively slow protein degradation rate for 
transcriptional control (or both protein and mRNA degradation rates when mRNA is more 
stable); in contrast, the output protease decays at a much faster rate because, in addition to 
regular protein degradation, it is also cleaved by input protease, and the rate is even higher when 
the input is switched to its active state. 
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Figure S1 | Characterization and optimization of CHOMP components. A, Three 
representative log-log flow cytometry scatter plots showing autofluorescence (blue) as well as 
reporter co-transfected with (purple) and without (orange) TEVP. Citrine signal is represented on 
the y-axis and the co-transfection marker mCherry on the x-axis. Dashed lines indicate the gate 
on mCherry expression analyzed in Fig. 1B. The histograms and data points are the same as in 
Fig. 1B, except for the additionally displayed autofluorescence distribution. B, Dose-response 
curves for activatable (left) and repressible (right) TEVP reporters (indicated schematically 
above each plot). The solid lines are fits based on the same equations as those used in bandpass 
analysis. C,D, Reporters activatable (left) and repressible (right) by TVMVP (C) and HCVP (D). 
The designs are identical to those of the TEVP reporters with two exceptions: First, the specific 
cleavage site sequences have been replaced with those of the regulatory protease. Second, the 
repressible HCVP reporter contains an additional leucine zipper compared to the other 
constructs, and it exhibits stronger repression when HCVP is tagged with the complementary 
leucine zipper (both shown in schematic, right-hand side of (D). E, Incorporating a leucine 
zipper (zig-zag) on HCVP (left) enhances repression of TEVP but has minimal effects when used 
on TVMVP (right). F, Alignment of TEVP and TVMVP sequences enables identification of 
TVMVP split site (vertical bars). G, A similar design enables repression of split TVMVP by 
TEVP. H, TVMVP can repress a single-chain TEVP. I, The single-chain TVMVP is repressed 
by HCVP (left) and TEVP (right). J, An alternative three protease cascade, distinct from that in 
Fig. 1G, can also propagate signals.  
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Figure S2 | Expanded schematics for logic gates and characterization of OR, AND, and 
NOR logic gates. A, Expanded schematic diagrams of logic gates for each input state. For each 
gate, the corresponding diagram is shown on top, followed by the expected behavior in each of 
the four input states, with or without TEVP (yellow) and HCVP (red). The presence of Citrine 
(green) indicates the “ON” output state, while degraded Citrine (shown as chopped up reporter) 
represents the “OFF” state. B, Responses of logic gates across 16 input concentration 
combinations for OR, AND, and NOR gates. Fluorescent intensities are normalized to the 
corresponding reporter stabilized with TMP (OR and NOR) or TMP and SHIELD1 (AND). In 
each case, reporter was used at a concentration of 150 ng. C, Varying reporter expression levels 
by transfecting OR, AND, and NOR reporter plasmids at 30 ng and 150 ng. Left axis displays 
fluorescent intensity values normalized to reporter stabilized with TMP or TMP and SHIELD1. 
Inputs TEVP and HCVP at 150 ng each. Right axis shows raw fluorescent intensity values. 
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Figure S3 | Expanding the inputs and complexity of logic gates. A, Characterization of OR, 
AND, and NOR gates using small molecule inputs. Asunaprevir (ASV), an inhibitor of HCVP and 
rapamycin, a chemical inducer of dimerization of a FRB/FKBP and thereby an inducer of split 
TEVP, were used as inputs. Each plot shows the output behavior in the presence or absence of 
each of the two small molecule inputs. The expected presence or absence of input protease 
activities is shown below the inducer rows. B, NOR gates can be composed. Left, diagram of 
nested NOR gate. Soybean mosaic virus protease (SMVP) and herpes simplex virus Protease 
(HSVP) are inputs to HCVP activity. HCVP and TEVP are, in turn, inputs to TVMVP. Finally, 
TVMVP stabilizes the Citrine reporter. Right, performance of the nested NOR gate with protease 
inputs SMBVP, HSVP, and TEVP indicated in graph. SMVP at 80 ng, HSVP at 150 ng, TEVP at 
30 ng, HCVP at 100 ng, and TVMVP at 100 ng.  
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Figure S4 | Characterization of 
bandpass and pulse-generation circuits. 
A, Linear correlation between the amount 
of transfected DNA and Citrine expression 
from CMV promoter. B, Bandpass 
behavior in response to TEVP and 
TVMVP expressed at constant DNA 
concentration but with different levels of 
induction by tetracycline analog 4-epi-Tc, 
x-axis). C, A TEVP variant activated by 
rapamycin-mediated dimerization of 
FKBP and FRB domains exhibits 
rapamycin-dependent activation. D, Left, 
diagram for activation of the IFP reporter 
by TEVP cleavage. Right, flow cytometry 
analysis of the dynamics of the pulse 
generation circuit (also see Figs. 3E,F for 
diagrams). Each dot represents the mode 
of the reporter fluorescence distribution at 
each time point. These data were obtained 
with the same stable cell line as in Fig. 3H.  
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Figure S5 | Characterization and optimization of circuits that selectively activate Casp3 in 
response to Ras activation. A, Expanded schematic diagram of the full circuit and each of its 
regulatory interactions (numbered arrows and corresponding boxes). B, Example of reduction 
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index analysis. The reduction index is calculated by comparing the number of surviving 
transfected cells in experimental vs. Citrine-only conditions, normalized to their respective 
untransfected populations, as shown in the equation. See also Methods for more details. Blue and 
red dashed lines indicate individual Gaussian distributions in the two-component fit, and purple 
dashed line indicates their sum. Blue shaded area is the area beneath the blue dashed line, and 
red shaded area is total area (grey histogram) minus blue shaded area (not the area beneath the 
red dashed line). C, Response of RasTEVP to physiological ligand epidermal growth factor, 
EGF. Left, diagram for activation of the membrane-localized IFP reporter (same as iTEV used in 
the pulse circuit (Fig. 3E) but with an additional 12 amino-acid N-terminal signal peptide from 
Lyn for membrane localization) by RasTEVP cleavage upon EGF stimulation. Right, co-
transfection of iTEV reporter and RasTEVP or constitutively dimerized membrane-localized 
TEVP (‘neg ctrl TEVP’). Left two bars show RasTEVP activation in response to EGF. Right two 
bars show negative control TEVP’s relatively lower response to EGF stimulation. These 
transfections included 25 ng of RasTEVP and 5 ng each for the negative control TEVP 
components. EGF was used at 25 ng/mL. D, Cytoplasmic TEVP-activatable Casp3 causes 
limited reduction of cell number in the presence of membrane-localized TEVP reconstituted 
through leucine zippers (compare to Fig. 4B). E, Reduction index is unaffected by SOSCA status 
in the presence of constitutive Casp3 activation with no Ras-dependent regulation (Casp3 not 
depicted). For the left bars, TEVP is constitutively active through the membrane-tethered leucine 
zippers. The right bars uses a G12V mutation in Ras that renders it constitutively active (65). F, 
The effects of RasTEVP and Casp3 doses on reduction index. Each bar represents the reduction 
indices from indicated concentrations of RasTEVP and Casp3 plasmids in control or SOSCA 
cells. G, Dose of TVMVP tunes the circuit’s selectivity for SOSCA cells (the first and fourth pairs 
of bars also shown in Fig. 4C). 90 ng of RasTEVP and Casp3 were transfected in each case.  
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Figure S6 | Further 
characterization and 
optimization of circuits that 
selectively activate Casp3 in 
response to Ras activation. A, 
Analysis of  contributions of 
individual regulatory edges in 
panel S5A to overall selectivity. 
Left, removing TVMVP ⊣ 
Casp3 (Arm 3) increases 
reduction index for both control 
and SOSCA cells; middle, 
removing RasTEVP ⊣ TVMVP 
(Arm 4) decreases reduction in 
SOSCA cells; right, removing 
TVMVP ⊣ RasTEVP (Arm 5) 
has no significant effect. We 
also note that, despite the 
qualitatively consistent 
selectivity, there is quantitative 
day-to-day variability. B, IRES 
variants with reported strengths 
of 30% and 70% of wild-type 
strength can be used to optimize 
TVMVP expression level in a 
single transcript. The IRES 
variant reported to express at 
~70% level of wild type (61) 
balances survival of control 
cells and reduction of SOSCA 
cells. 200 ng for each single-
transcript variant.  C, 
Optimizing transfection dose for 
full single-transcript circuit with 
70% IRES. Each pair of bars 
represents 4 replicate co-
cultures (gray dots) of control 
and SOSCA cells transfected 
with the indicated amount of the 
single-transcript circuit.  D, 
Annexin V staining of control, 
SOSCA and EGFRvIII+ cells. 
Transfection of a negative 
control, full circuit and the 
positive control circuit from Fig 
4D into each cell line at 50 ng each. We note that the fraction of apoptotic cells in all conditions 
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are smaller than what would be indicated by reduction index, as expected due to heterogeneity in 
the timing of initiation of apoptosis and the loss of Annexin-V+ cells due to cell death. The two 
effects together cause any given time window to capture only a fraction of the cumulative 
number of Annexin-V+ cells over the whole time-course.  
 
 
  
  
24 
 
 
 
Figure S7. Simulated protease-protease and TF-TF regulation dynamics. This plot compares 
the dynamic response of protease-protease regulation (blue) and transcriptional regulation (pink 
and red, representing distinct parameter sets) to step changes in an input protease/TF (black line). 
See Supplementary text for models and parameter values. 
 
  
0 50 100 150
time (h)
OFF
ON
in
p
u
t
0 50 100 150
time (h)
0
0.5
1
n
o
rm
a
liz
e
d
 o
u
tp
u
t
Protease
TF, less stable mRNA
TF, more stable mRNA
  
25 
 
 
Table S1. List of plasmids constructed for this study and their use in figures. 
Movie S1. Time-lapse movie of four representative cells displaying pulsing signal. 
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